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Abstract
Background. Existing analyses of nonpharmaceutical interventions (NPIs) against COVID-
19 transmission have concentrated on the joint effectiveness of large-scale NPIs. With in-
creasing data, we can move beyond estimating joint effects towards disentangling individual
effects. In addition to effectiveness, policy decisions ought to account for the burden placed
by different NPIs on the population.
Methods. To our knowledge, this is the largest data-driven study of NPI effectiveness to
date. We collected chronological data on 9 NPIs in 41 countries between January and April
2020, using extensive fact-checking to ensure high data quality. We infer NPI effectiveness
with a novel semi-mechanistic Bayesian hierarchical model, modelling both confirmed cases
and deaths to increase the signal from which NPI effects can be inferred. Finally, we study
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how much perceived burden different NPIs impose on the population with an online survey
of preferences using the MaxDiff method.
Results. Eight NPIs have a >95% posterior probability of being effective: closing schools
(mean reduction in R: 50%; 95% credible interval: 39%–59%), closing nonessential busi-
nesses (34%; 16%–49%), closing high-risk businesses (26%; 8%–42%), and limiting gath-
erings to 10 people or less (28%; 8%–45%), to 100 people or less (17%; -3%–35%), to 1000
people or less (16%; -2%–31%), issuing stay-at-home orders (14%; -2%–29%), and test-
ing patients with respiratory symptoms (13%; -1%–26%). As validation is crucial for NPI
models, we performed 15 sensitivity analyses and evaluated predictions on unseen data,
finding strong support for our results. We combine the effectiveness and preference results
to estimate effectiveness-to-burden ratios.
Conclusions. Our results suggest a surprisingly large role for schools in COVID-19 trans-
mission, a contribution to the ongoing debate about the relevance of asymptomatic carri-
ers in disease spread. We identify additional interventions with good effectiveness-burden
tradeoffs, namely testing symptomatic individuals, closing high-risk businesses, and limit-
ing gathering size. Closing most nonessential businesses and issuing stay-at-home orders
impose a high burden while having limited additional effect.
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1. Introduction
The governments of the world have mobilized vast resources to fight the COVID-19 pan-
demic. A wide range1 of nonpharmaceutical interventions (NPIs) has been deployed, in-
cluding drastic measures like national lockdowns and the closure of all non-essential busi-
nesses. Recent analyses show that these large-scale NPIs appear to be jointly effective at
reducing the virus’ effective reproduction number.2 As time progresses, more data becomes
available from different countries that have implemented various NPIs (Figure 1). We can
thus move beyond estimating the aggregate effect of a bundle of NPIs and understand the
effect of individual NPIs.
But, selecting the right policy depends on more than estimates of effectiveness. Drastic
NPIs, such as society-wide social distancing, cause widespread disruption to many aspects
of social life, including quality of life, economic prospects,3 and, potentially, the mental
health of the entire population.4 When selecting policies, it is thus important to consider
the burden they impose.
This paper’s aim is to estimate the effectiveness of various NPIs at reducing the spread of
COVID-19 and their associated burden on the population.
To disentangle individual NPI effects, we need to leverage data from multiple regions with
diverse bundles of NPIs. With some exceptions (Flaxman et al.2, Chen and Qiu5, and
Banholzer et al.6), previous data-driven studies focus on single NPIs and/or single regions
(Table 1). In contrast, we evaluate the impact of 9 NPIs on the growth of the epidemic in 34
European and 7 non-European countries. To our knowledge, this is the largest data-driven
model of NPI effects on COVID-19 transmission to date. Additionally, the focus of previous
work has largely been on costly NPIs (Table 1). In line with our aim of identifying effective
interventions with little burden, we additionally analyse the effects of several less disruptive
NPIs (Table 2).
Before collecting data, we experimented with two public datasets on NPIs, finding that
they contained some incorrect dates and were not complete enough for our modelling.a By
focusing on a smaller set of countries and NPIs than is present in these datasets, we were
able to implement strong quality controls in our data collection. We make this high-quality
dataset public, as well as the Epidemic Forecasting Global NPI database, a much larger but
less rigorously verified dataset.
aWe evaluated the following datasets:
• Oxford COVID-19 Government Response Tracker (OxCGRT)7
• #COVID19 Government Measures Dataset8
Note that these datasets are under continuous development. Many of the mistakes we found will already have
been corrected. Also, we know from our own experience that data collection can be very challenging. We
have the fullest respect for the work of the people behind these datasets. In this paper, we focus on a much
more limited set of countries and NPIs than these datasets contain, allowing us to ensure higher data quality in
this subset. Given our experience with public datasets and our data collection, we encourage fellow COVID-19
researchers to independently verify the quality of public data they use, if feasible.
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To estimate NPI effectiveness, we design a novel semi-mechanistic Bayesian hierarchical
model with a time-delayed effect for each NPI. A key assumption of our model is that the
effect of each NPI on the reproduction number is stable across different countries and over
time. This assumption is present in all closely related works. Our model can be seen as an
extension to that of Flaxman et al.,2 using both confirmed cases and deaths as observations
to increase the amount of signal available for inferring NPI effects.
Constructing an NPI model is a perilous task since its conclusions can be sensitive to the
assumptions and data. Therefore, it is crucial to validate it. However, such validation is
often incomplete or absent from previous work. We perform what is, to our knowledge, by
far the most extensive validation of any NPI model for COVID-19 to date—evaluating pre-
dictions for countries and time periods not seen during training (Figures 4 & 5), evaluating
different models that use different observations (deaths and confirmed cases; Figure 6),
testing robustness to unobserved NPIs (Figure D.10), and analyzing sensitivity to many per-
turbations (Appendix D). Nonetheless, our model comes with important limitations and
uncertainties, which we discuss in Appendix H.
Finally, to study how burdensome people perceive different NPIs to be, we collected prefer-
ence data using a best-worst scaling9 discrete choice online survey instrument. As commu-
nity surveys are often successfully used in public health settings to estimate the preferences
over various treatments and interventions,10 we believe this data can provide valuable in-
put when evaluating NPIs. While there are many other ways to estimate NPI cost, for
example by modelling economic impacts, these are often dominated by long-term effects.
For example, a large part of the economic impact of closing schools could consist in human-
capital loss.11 These long-term effects are currently hard to predict and are codetermined
by economic policy responses and many other effects beyond the scope of this study.
Summary of contributions:
• High-quality data on the largest number of countries and NPIs studied to date, includ-
ing several less costly NPIs
• A novel combined model utilising both confirmed cases and deaths
• Extensive model validation
• Estimation of population preferences over NPIs and analysis of effectiveness-burden
tradeoffs
4
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Table 1: Existing data-driven studies of the effectiveness of observed (as opposed to hypothetical) NPIs
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We collected a large database from 67 countries, which we call the Epidemic Forecasting
Global NPI (EFGNPI) database. The database contains more than 1700 events, tagged with
194 keywords, which are distilled into 24 classes of NPIs. Details of the EFGNPI database
are given in Appendix B.
As described in the introduction, we found that public datasets on NPIs contained frequent
incorrect entries. We expect the same to be true for the full EFGNPI database. For the
smaller set of NPIs and countries used in this study, we implemented further steps to ensure
data quality (see below). The data used in this study, including sources, can be found at
https://github.com/robust-npis/covid-19-npis.
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Table 2: NPIs included in the modelling dataset
NPI Description
Mask-wearing
One or both of:
• a country has implemented a policy of requiring mask usage among
the general public, sometimes limited to certain domains like a duty
to wear masks in public transportation and supermarkets




Testing is available to anyone showing COVID-19 symptoms (as defined





A country has set a size limit on gatherings. The size limit is at most
1000 people (often less) and gatherings above the maximum size are
disallowed. For example, a ban on gatherings of 500 people or more
would be classified as “gatherings limited to 1000 or less” but a ban on




A country has set a size limit on gatherings. The size limit is at most





A country has set a size limit on gatherings. The size limit is at most 10




A country has specified a few kinds of customer-facing businesses that
are considered “high risk” and need to suspend operations (blacklist).
Common examples are restaurants, bars, nightclubs, and gyms. By de-
fault, businesses are not suspended.
Most nonessential
businesses closed
A country has suspended the operations of many customer-facing busi-
nesses. By default, customer-facing businesses are suspended unless
they are designated as essential (whitelist).
Schools closed
A country has closed many or all schools. (Note that this was accompa-




An order for the general public to stay at home has been issued. This is
mandatory, not just a recommendation. Exemptions are usually granted
for certain purposes (such as shopping, exercise, or going to work), or,
more rarely, for certain times of the day. In practice, a stay-at-home
order was often accompanied by other NPIs such as businesses closures.
However, a stay-at-home order does not in principle entail these other
NPIs, but only the (additional) order to generally stay at home except
for exemptions.
dFeature taken from the Oxford COVID-19 Government Response Tracker7
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We analyse 41 countriesc (see Figure 1) and 9 NPIs (Table 2). We only recorded when NPIs
were implemented in most of a country. The window of analysis spans the period from 22nd
January to 25th April 2020d, inclusive. Data on confirmed COVID-19 cases and deaths were
taken from the John Hopkins Center CSSE COVID-19 Dataset24,25.
Data collection
Gathering bans, school closure, business closure, stay-at-home order
For each NPI and each country, one to three contractors independently collected data on
the start date of the NPI, including sources. Each country was then extensively researched
by one of the authors, using media articles, government sources, and Wikipedia articles.
The researcher finalised the data based on their research, the data in the EFGNPI dataset,
the data provided by the contractors, and, if available, data from the Oxford COVID-19
Government Response Tracker.7
Mask-wearing
To estimate the local prevalence of mask-wearing, we conducted surveys of n=908 par-
ticipants from most of the countries studied. Respondents were asked about the number
of people they had seen wearing masks (details in Appendix C). We also used Wikipedia
and the masks4all dataset26 to ascertain when countries mandated mask-wearing in (some)
public places. In all countries in which the government mandated mask-wearing, our sur-
vey results indicate that more than 60% of people started wearing masks around the time
when the mandate was implemented.
Testing
The Oxford COVID-19 Government Response Tracker7 has complete data on testing policies
implemented in different countries. To check its accuracy, we compared the data with the
number of tests per confirmed case27 and found that activation of the testing feature was
correlated with a substantial increase in the number of tests per confirmed case. We did not
do further verification. As of version 5.0 of the dataset, our “symptomatic testing” feature
corresponds to the following feature in the OxCGRT dataset: ID H2, levels 2-3.
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Figure 1: Timing of NPI implementations. Crossed-out symbols signify when an NPI was lifted.
9
 . CC-BY-NC 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted June 2, 2020. .https://doi.org/10.1101/2020.05.28.20116129doi: medRxiv preprint 
For each country c
For each day t
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 = 1 if  is onϕi,t,c i
For each intervention i
Figure 2: Model Overview. Purple nodes are observed or have a fixed distribution. The same structure is
used for both deaths and confirmed cases. Our primary model combines both observations; it splits all
nodes above the daily growth rate gt ,c into separate branches for deaths and cases.
2.2. Model
We construct a semi-mechanistic Bayesian hierarchical model, similar to Flaxman et al.2 The
main difference is that we model both confirmed cases and deaths, allowing us to leverage
significantly more data. Furthermore, we do not assume a specific infection fatality rate
since we do not aim to infer the total number of COVID-19 infections. The end of this
section details further adaptations which allow us to make minimal assumptions about
testing, reporting, and the infection fatality rate (IFR). Please see Appendix F for further
details.
We describe the model in Figure 2 from bottom to top. The growth of the epidemic is de-
termined by the time-and-country-specific reproduction number Rt ,c . It depends on: a) the
basic reproduction number R0,c without any NPIs active, and b) the active NPIs. We place
a prior (and hyperprior) distribution over R0,c , reflecting the wide disagreement of regional
cThe countries were selected by a case threshold (at the time of modelling), the availability of reliable data
on NPIs, and how trustworthy we estimated the reporting of deaths from this country to be. Some particular
countries were excluded for specific reasons. For example, we excluded South Korea because the country made
heavy use of contact tracing which we don’t model (because data on contact tracing is very hard to get).
d22nd January - 17th April for confirmed cases
10
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estimates of R0.28 We parameterize the effectiveness of NPI i , assumed to be similar across
countries and time, with αi . The effect of each NPI on Rt ,c is assumed to be multiplicative
(and therefore independent) as follows:








where φi ,c,t = 1 means NPI i is active in country c on day t (φi ,c,t = 0 otherwise). In Section 3,
we discuss this interaction between NPIs. There is a symmetric prior (and hyperprior) over
αi , allowing for both positive and negative effects.
Growth rates. Nt ,c denotes the number of new infections at time t and country c. In the
early phase of an epidemic, Nt ,c grows exponentially with a dailye growth rate g t ,c . During
exponential growth, there is a well-known one-to-one correspondence between g t ,c and
Rt ,c :29
Rt ,c = 1
M(− log(1+ g t ,c ))
, (1)
where M(·) is the moment-generating function of the distribution of the serial interval (the
time between successive cases in a chain of transmission). We assume that the serial interval
distribution is given by a Gamma(5.18, 0.96)f distribution30. Using (1), we can write g t ,c
as g t ,c (Rt ,c ) (see Appendix F).
Infection model. Rather than modelling the total number of new infections Nt ,c , we model
new infections that either will be subsequently a) confirmed positive, N (C )t ,c , or b) lead to a
reported death, N (D)t ,c . They are backwards-inferred from the observation models for cases
and deaths, shown further below. We assume that both grow at the same expected rate g t ,c :


















where ε(·)τ,c ∼N (0,σN = 0.2) are separate, independent noise terms. We seed our model with
unobserved initial values, N (C )0,c and N
(D)
0,c , which have uninformative priors.
g
eMany epidemiological models define growth rates as the exponent r in an exponential growth function.
Here, we use daily growth rates instead for ease of exposition. These choices are mathematically equivalent.
Note that we adapted equation (2.9) in Wallinga & Lipsitch29 to account for our choice.
fThe two parameters are the shape and rate. The mean is 5.1 days.
gSince we treat new infections as a continuous number, its initial value can (and often should) be between
0 and 1.
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Observation model for confirmed cases. The mean predicted number of new confirmed cases
is a discrete convolution
C t ,c =
t∑
τ=1
N (C )t−τ,c PC (delay= τ) (4)
where PC (delay) is the distribution of the delay from infection to confirmation. This delay
distribution is the sum of two independent gamma distributions: the incubation period
and the delay from onset of symptoms to confirmation. We use previously published and
consistent empirical distributions from China and Italy,31–34 which sum up to a mean delay
of 10.35 days. Finally, the observed cases Ct ,c follow a negative binomial noise distribution
with mean C t ,c and an inferred dispersion parameter, following Flaxman et al.2
Observation model for deaths. The mean predicted number of new deaths is a discrete
convolution
D t ,c =
t∑
τ=1
N (D)t−τ,c PD (delay= τ),
where PD (delay) is the distribution of the delay from infection to death. It is also the sum
of two independent gamma distributions: the aforementioned incubation period and the
delay from onset of symptoms to death31,35, which sum up to a mean delay of 23.9 days.
Finally, the observed deaths D t ,c also follow a negative binomial distribution with mean D t ,c
and an inferred dispersion parameter.
Single and combined models. To construct models which only use either confirmed cases or
deaths as observations, we remove the variables corresponding to the disregarded observa-
tions.
Testing, reporting, and infection fatality rates. Scaling all values of a time series by a con-
stant does not change its growth rates. The model is therefore invariant to the scale of the
observations and consequently to country-level differences in the IFR and the ascertainment
rate (the proportion of the infected cases who are subsequently reported positive). For ex-
ample, assume countries A and B differ only in their ascertainment rates. Then, our model
will infer a difference in N (C )t ,c (Eq. (4)) but not in the growth rates g t ,c across A and B (Eq.
(2)-(3)). Accordingly, the inferred NPI effectiveness will be identical.h
In reality, a country’s ascertainment rate (and IFR) can also change over time. In principle,
it is possible to distinguish changes in the ascertainment rate from the effects of NPIs:
decreasing the ascertainment rate decreases future cases Ct ,c by a constant factor whereas
hThis is only approximately true. The negative binomial output distribution has a coefficient of variation di-
minishing with its mean i.e., smaller observations are relatively more noisy and carry less weight. Furthermore,
whilst the prior over N (C )0,c could break scale invariance, the uninformative prior results in a negligible effect.
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the introduction of an NPI decreases them by a factor that grows exponentially over time.i




(Eq. (2)), mimic changes in the ascertainment rate—noise at time
τ affects all future cases—and allow for gradual, multiplicative changes in the ascertainment
rate.
We infer the unobserved variables in our model using Hamiltonian Monte-Carlo36,37 (HMC),
a standard MCMC sampling algorithm.
The model code can be found at https://github.com/robust-npis/covid-19-npis.
2.3. Preference elicitation
We collected preference data to study the direct impact of NPIs on people’s lives. We used
a best-worst scaling discrete choice survey instrument, specifically MaxDiff,9 and surveyed
N = 474 US residents recruited on Amazon’s Mechanical Turk platform. The platform typi-
cally yields participants with greater demographic diversity than typical internet samples.38
Note that this survey was entirely separate from the survey used for studying mask-wearing
described above.
Each respondent was given a short description of all studied NPIs (Appendix G) and then
presented with 12 MaxDiff questions with 6 options, where each option consisted of a
type of NPI and a duration (1 week, 2 weeks, 1 month, 3 months, 6 months, 1 year).
Participants were asked to select the two options that they perceived as overall least and
most burdensome (example question in Appendix G).
Before analysis, 140 responses with inconsistent answers were discarded; we considered
answers erroneous when they preferred a longer duration of an intervention (often this
happened for participants who responded quickly). To extract utility scores, we used the
analytical estimation for the multinomial logit model,39 as implemented in the bwsTools
package40 in R.
2.4. Effectiveness-Burden-Ratio
To analyse how the effectiveness of NPIs compares to their social impact, we can use the
utility scores derived from the survey responses. However, utility scores are on an interval
scale, because the survey only asks for relative comparisons between options.41 While re-
spondents presumably dislike all choices, we cannot say that, for example, a stay-at-home
order is three times worse than school closure.
iHowever, our model may struggle when the ascertainment rate also changes exponentially over time. This
could happen when a country reaches its testing capacity. See Appendix H.
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To estimate the effectiveness-burden-ratio, we need to estimate a measure for the interven-
tion burden on a ratio scale, which we call “perceived intervention costs”. These can be
derived from the utility scores with additional assumptions, which are well justified by the
empirical data (Figure 7, details in Appendix G).
With these, the effectiveness-burden-ratio EBRi of intervention i can be defined as:j
EBRi =− ln(mi )
ci
where mi is the multiplicative factor on R (e.g., for a 20% reduction in R, mi = 0.8), and ci
is the cost of intervention i . To determine the error of EBRi , we used error propagation:42
V (EBRi ) = V (mi )
(mi · ci )2
+ ln(mi )
2 ·V (ci )
c4i
where V (·) is the variance.
2.5. Ethics
The online survey experiments were approved by the Medical Sciences Interdivisional Re-
search Ethics Committee at the University of Oxford (Ethics Approval Reference: R69410/RE001)
2.6. Role of the funding source
The funding source did not influence any aspect of study design, execution, or reporting.
3. Results
3.1. International timeline of NPI implementation
We aim to estimate the effectiveness of individual NPIs. If all countries implemented the
same set of NPIs, on the same day, the individual effect of each NPI would be unidentifiable.
However, many countries implemented different sets of NPIs, at different times, in different
orders (Figure 1).
jThis particular functional form is chosen because it is a simple expression that satisfies three desirable
properties:
i) repeated application of an intervention x times that has effectiveness factor m and a constant unit cost c
has equal effectiveness-burden-ratio each time it is applied. Formally: for any c ∈ R+ and any m ∈ (0,1),
we have that f (mx , xc) = f (m,c) for any x ∈Z.
ii) it is increasing in m
iii) it is decreasing in c
14
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3.2. Model fits
The model fits the observations well in 3 randomly selected countries (Figure 3, left). The
fits for all other countries can be found in Appendix E. Plotting posterior values of the
noise terms ε(C )t and ε
(D)
t shows periods where infections grew faster or slower than pre-
dicted based on the active NPIs, illustrating where the model might account for unobserved
interventions or changes in reporting.
3.3. Held-out data experiments
An important way to validate a Bayesian model is by checking its predictions on held-out
data.43 Our model makes sensible, calibrated forecasts over long periods in countries whose
data was not used to infer the effectiveness of NPIs (Figure 4, see Appendix E for other
countries).
We additionally validate our model’s predictions by holding out the last 20 days of both new
cases and deaths for all countries. These are challenging predictions; the longest attempted
period we found in related work was 3 days.2 The accurate forecasts in Figure 5 provide
strong empirical evidence that our estimates of R are plausible.
3.4. Effectiveness per NPI
The estimates of NPI effectiveness are our main result. To interpret them correctly, we need
to keep in mind that our model assumes no interaction between different NPIs. In our
model, each NPI reduces R by a multiplicative factor, independent of the context, i.e., the
presence of other NPIs. This independence assumption is present in all multi-NPI studies
we are aware of and seems reasonable for many NPIs. For instance, the effectiveness of
closing businesses is likely to be similar whether or not schools are closed. However, in
some situations, the effectiveness of an NPI might depend on its context. For example, if a
stay-at-home order is in place, a larger fraction of the remaining transmission might occur
in private spaces, and wearing masks in public spaces might be less effective.
Given this discussion, the effectiveness estimates should not be interpreted as the average
effectiveness across all possible contexts, but rather as the (additional) effectiveness aver-
aged across the contexts in which the NPI was present in our data. This result, which is
equally important for the interpretation of other related studies, is derived for a simplified
model in Appendix F.3. Figure 6 (bottom left) visualises the contexts of each NPI in our
data, aiding interpretation.
Figure 6 shows the estimates of NPI effectiveness. Reassuringly, our three models have
similar results. This suggests that results are not biased by factors that are specific to the
deaths or cases model, such as changes in the ascertainment rate, reporting, and model-
specific time delays. All NPIs except mask-wearing had a >95% posterior probability of
being effective.
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Figure 3: Model fits for 3 randomly selected countries. Vertical lines show the activation of NPIs. Shaded
areas are 95% credible intervals. Left: Country-level estimates of daily new infections N (C )t and N
(D)
t ,
smoothed confirmed cases Ct , and deaths Dt . Note that the curves show the fit to data, and not epi-
demiological forecasts. Middle: Estimates of reproduction numbers. Right: Inferred noise ε(C )t and ε
(D)
t
on new infections. Values above zero indicate that infections grew faster than predicted solely based on
the active NPIs.
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Figure 4: Predictions for held-out countries. We randomly selected 6 countries with >100 deaths. Empty
dots are not shown to the model. 14 initial days are shown to the model, to enable inferring the country-
specific R0.
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Figure 5: Predictions for held-out last 20 days. These results were obtained by holding out the last
20 consecutive days for all countries and predicting them (these days were not available to infer NPI
effectiveness). Each point represents a country. The plot shows 95% sampled posterior credible intervals
and the median predicted values.
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Figure 6: Top: Posterior reduction in R for each NPI. The plot shows 50% and 95% credible intervals.
A negative 1% reduction refers to a 1% increase in R. The following NPIs are hierarchical: gathering
bans and business closures. For example, the result for Most Businesses Suspended shows the cumulative
effect of two NPIs with separate parameters and symbols: suspending some (high-risk) businesses, and
suspending most remaining (non-high-risk, but nonessential) businesses. The exact numbers are given
in Appendix A. Bottom Left: The conditional activation matrix shows the situations encountered in our
data. Cell values indicate the frequency that NPI i (x-axis) is active given that NPI j was active(y-axis)
e.g., schools were closed whenever a stay-home-order had been issued (bottom row, second column from
the right), but not vice versa. Bottom Right: Total number of days each NPI was active across countries.
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We confirmed the quality of the MCMC inference with the Gelman-Rubin convergence statis-
tic44 (Appendix E).
3.5. Sensitivity experiments
We ran a wide range of sensitivity experiments on our combined model. Appendix D
shows effectiveness-per-NPI plots for the many conditions we tested. Table 3 summarizes
the results qualitatively. We diagnosed ‘low - moderate’ sensitivity when, for every NPI, all
95% credible intervals, but not all 50% intervals, overlap. ‘Low’ sensitivity means all 50%
intervals overlap.
Results were stable, not affecting our conclusions.
Table 3: Sensitivity of effectiveness estimates. Summary of the results in Appendix D. ‘Low - moderate’
sensitivity means that all 95% credible intervals overlap for all NPIs. ‘Low’ means all 50% intervals
overlap.
Sensitivity to Sensitivity
Mobility data as ‘NPI’
Mobility explains only the ef-
fect of business closures and
stay-home-orders
Unobserved NPIs
Low, but moderate for re-
moval of most effective NPI
Left-out countries Low
Delay to confirmation Low
Delay to death Low
Standard deviation of the








Serial interval mean Low - moderate
Minimum cumulative
cases before which data
is masked
Low
Prior over effectiveness Low - moderate





 . CC-BY-NC 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted June 2, 2020. .https://doi.org/10.1101/2020.05.28.20116129doi: medRxiv preprint 
Robustness to unobserved effects. The model assumes that there are no unobserved factors
changing R (i.e., unobserved confounders such as spontaneous social distancing). But this is
not necessarily true in practice. We test robustness to unobserved factors by computing NPI
effectiveness whilst removing the observation of each NPI in turn. The sensitivity is low,
supporting the claim that the model successfully unobserved factors.
Furthermore, we investigated robustness to unobserved confounding factors by including
mobility data45 as an ‘NPI’ that serves as a proxy for behaviour changes. We find that
the mobility data explains the effect of business closures and stay-home-orders, which is
expected as the effect of these NPIs is mediated through retail and recreation mobility. The
inferred effectiveness of other NPIs is unchanged.
We do not report sensitivity to:
• The prior over the initial outbreak size N0,c (because it is already extremely wide,
having a negligible effect)
• Alternative models of infection and NPI interaction
3.6. Preference elicitation
We surveyed 474 US residents recruited on Amazon’s Mechanical Turk platform about their
preferences regarding various NPIs using a best-worst scaling survey. 140 responses were
filtered for internally inconsistent answers, and 334 were used for subsequent analysis (de-
mographics in Appendix G). The NPI Symptomatic testing was not included in the prefer-
ence elicitation because the mere option to get tested for Covid-19 when having symptoms
does not impose any burden on people.
The ranking of the NPIs is largely independent of the duration (Figure 7). The duration-
dependence of preferences is largest for mask-wearing, which is more preferable if required
only briefly, and the most stringent interventions, stay-at-home orders and the closure of
most nonessential businesses, which are perceived as particularly bad if implemented for
unrealistically long durations. Table A.4 displays the aggregate utility scores across all
durations.
3.7. Effectiveness-Burden-Tradeoff
Figure 8 compares the effectiveness of different NPIs to survey participants’ preferences.
With some further assumptions (see Section 2.4), we can convert the utility scores to a
ratio-scaled measure of intervention burden and calculate an effectiveness-burden-ratio for
every NPI (Figure 9).
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Gatherings limited to 1000 people or less
Gatherings limited to 100 people or less
Gatherings limited to 10 people or less
Some businesses closed
Most nonessential businesses closed
Schools closed
Stay-at-home order (with exemptions)
Figure 7: NPI disutility scores in dependence of the duration of the intervention. Lower disutility implies
higher utility and a stronger preference. Utilities are on an interval scale, the absolute values have no sig-
nificance, only differences between utilities carry meaning. The error bars indicate the 95% confidence
interval.
4. Discussion
We find evidence for the effectiveness of several NPIs. The conclusions discussed here were
robust across 15 sensitivity analyses.
Combining effectiveness estimates with results from preference surveys, we can draw inter-
esting conclusions:
• Closing high-risk businesses, such as bars and restaurants, appears only slightly less
effective than closing most nonessential businesses, while imposing a substantially
smaller burden.
• There is no obvious best choice for gathering-size restrictions: though stricter limits
are more effective, they are more burdensome, giving a similar effectiveness-burden
ratio.
We now discuss some of the main or more surprising results in detail.
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Gatherings limited to 10 people or less
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Most nonessential businesses closed
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Stay-at-home order (with exemptions)
*Note that mask wearing was also the NPI with the least available data, 
which might explain the lack of observed effect.
Figure 8: Effectiveness of NPIs compared to survey participants’ preferences. The combined confirmed
cases + deaths model was used for the effectiveness estimates. The dashed line represents no effect.
Error bars indicate 95% credible/confidence intervals. The NPI Symptomatic testing was not included in
the preference survey because the mere option to get tested for Covid-19 does not impose any burden
on people. It is thus shown here on a separate x-axis.
0.25 0.00 0.25 0.50 0.75 1.00
Effectiveness-burden-ratio
Mask Wearing*      
Gatherings <1000      
Gatherings <100            
Gatherings <10                  
Some Businesses Suspended      
Most Businesses Suspended            
School Closure      









*Note that mask wearing was also 
the NPI with the least available data, 
which might explain the lack of 
observed effect.
Figure 9: Effectiveness-burden-ratio of NPIs. The combined active cases + deaths model was used to
generate the effectiveness estimates. The dashed line represents no effect. The error bars display the
standard deviation. The definition of the effectiveness-burden-ratio is given in Section 2.4.
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Testing. With no direct negative effects on the population and a demonstrable effect on
transmission, testing of patients with respiratory symptoms looks very promising from an
effectiveness-burden perspective.k Of course, the main negative effect of testing is the cost
of purchasing and conducting tests. However, a recent economic analysis concluded that
even testing asymptomatic people is vastly more cost-effective than indiscriminate mea-
sures.46.
Stay-at-home-orders. We estimate a comparatively small effect for stay-at-home orders.
The ‘stay-at-home order (with exemptions)’ NPI (Table 2) should be interpreted literally: a
mandatory order to generally stay at home, except for exemptions. When countries intro-
duced stay-at-home orders, they nearly always also banned gatherings and closed nonessen-
tial businesses and schools if they had not done so already (Figure 6). Accounting for the
effect of these NPIs, it is not surprising that the additional effect of ordering citizens to
stay at home is small-to-moderate. Accordingly, it may be acceptable to lift burdensome
stay-home-orders, provided other NPIs stay active. Our result agrees with Banholzer et al.6
(they call this NPI ‘lockdown’), and we have not seen contradictory results in related work.
In particular, the ‘lockdown’ NPI in Flaxman et al.2 includes several other NPIs. Chen &
Qui5 found a significant effect, but without defining ‘lockdown’.
Mask-wearing. Mask-wearing was often introduced towards the end of our analysis period
(Figure 1), meaning that it is, by far, the NPI with the least data (Figure 6). We conclude
that we have insufficient data to make claims about the effectiveness of mask-wearing, and
indeed, in most of our sensitivity analyses, the result for mask-wearing was the least robust
one (Appendix D). In particular, we do not conclude that mask-wearing is likely harmful.
Additionally, mask-wearing might have a reduced effect in the context of the particular
countries we studied. People started wearing masks when interactions in public spaces
were already limited by other NPIs. When relatively more transmission occurs in private
spaces, wearing masks in public is expected to be less effective. This might explain the
difference to Chen & Qui,5 who found a small significant effect of mask-wearing based on
data from two countries (China and South Korea), as mask-wearing was common in South
Korea before other NPIs were implemented.
School closures. All our models find a very large effect for school closures. This result is
surprising, even when accounting for the fact that school closure usually coincided with
university closure. However, the large effect was remarkably robust across our sensitivity
analysis, different structural assumptions (e.g., about infection and NPI interaction - not
reported) we implemented during our model checking process47, and across a long process
of collecting data for additional countries and NPIs. By inspecting the data and the in-
kNote that we did not directly measure the burden of testing because this is not possible in the framework
of our preference analysis (Section 3.6)
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ferred infections, it is easy to see why the effect is so large: school closures are consistently
followed by a clear reduction in growth (after the appropriate delay).
It is possible that our model confuses the effect of closing schools and unobserved be-
haviour changes. However, our sensitivity analysis showed that results are fairly robust to
unobserved NPIs, suggesting they are robust to unobserved factors. Furthermore, we di-
rectly modelled unobserved factors by introducing mobility data ‘NPIs’ as a proxy for them.
Again, the effect of school closures was unchanged. While these techniques closely mir-
ror well-established sensitivity checks for unobserved causal effects,48,49 they, too, rely on
assumptions.
A further concern is that school closures have a delayed effect on deaths and confirmed
cases, since children are less likely to die or show symptoms than adults. However, the
result is not sensitive to the mean delay we assume ( Appendix D).
Additionally, since the closure of schools was often the first major NPI introduced (Figure 1),
it may have caused public concern to increase, causing behaviour changes. We do not
distinguish this indirect signalling effect from the direct effect (for any NPI). Conversely,
reopening schools could also have a signalling effect.
Previous evidence relevant to school closures is mixed. Flaxman et al.2 and Banholzer et
al.6 did not find a significant non-zero effect with their data (Banholzer et al. focused on
primary schools). Limited data suggests that children are equally susceptible to infection
but have a lower observed case rate than adults50–52—whether this is due to school closures
remains unknown. There is insufficient data about transmission from children. However,
viral shedding appears to be comparable across age groups.53,54 Little is known about the
attack rate in schools (since they are closed); the best-documented case found that 38.3%
to 59.3% were infected in one French high school.55 As our results suggest a large role of
schools (and universities) in Covid-19 transmission, this topic deserves further study.
Our study is not without assumptions and limitations, which are discussed in greater detail
in Appendix H. To highlight some important points: NPI effectiveness may vary across
countries and time; we cannot quantify the influence of unobserved factors on our results;
regional differences within countries complicate the analysis. Therefore, a high degree of
uncertainty remains. Our results should not be seen as the final answer on NPI effectiveness
and burdens, but rather as a contribution to a diverse body of evidence, next to other
retrospective studies, experimental trials and clinical experience.
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Appendix A. Main results table
See next page. The effectiveness estimates are computed with the combined cases + deaths
model. For the disutility scores, lower disutility implies higher utility and a stronger pref-
erence. Utilities are on an interval scale, the absolute values have no significance, only
differences between utilities carry meaning. The zero point has no particular meaning.
We can, e.g., say that the preference for Some businesses closed over Stay-at-home order
was equally strong as the preference for Gatherings limited to 100 people or less over Some
businesses closed (ca. 0.3 a.u., arbitrary units)
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Appendix B. The Epidemic Forecasting Global NPI database
Appendix B.1. Overview
Up-to-date information on the Epidemic Forecasting Global NPI (EFGNPI) database can be
found at http://epidemicforecasting.org/containment.
The full database (DB) is a daily representation of the response of each of 97 countries. It
aims at collecting as broad a range of NPIs as possible. However, data on minor NPIs is
often hard to find. As a result, the absence of an entry does not necessarily mean that this
NPI was not implemented by a country.
A smaller dataset, the EFGNPI Features dataset (FD), is derived from the full DB. The FD
data aggregates many tags in the main database to produce a dataset easier to use in ma-
chine learning applications. The tags are also used to determine a stringency score for each
feature. (Please note that details of how the FD data is produced from the main database
may change slightly over time.)
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* The database contains data on 97 countries, but only 67 of these are complete at time of
writing.
Appendix B.2. Collection
The underlying data was gathered by a team of volunteers. The database integrates many
sources. Wikipedia entries were taken as a starting point for the set of NPIs implemented by
each country. These were then refined by reference to national centres for disease control.
The full database is recorded as a dataset of tags. We began without a predefined list
of attributes to record, so collection proceeded with a dynamic set of keyword tags as
data on national responses was collected. After the data had been collected, a method for
aggregating tags was created. The resulting database includes a ‘Source’ field for most rows.
Please note that the full EFGNPI database, in contrast to the data used in this study,
has not been subject to extensive fact-checking.
Appendix B.3. Comparison to other datasets
Table B.6: Comparison to other datasets. *The database contains data on 97 countries, but only 67 of











































It is important that researchers select the dataset appropriate for their use-case. We think
that a particular strength of the EFGNPI database is that it tracks a vast array of NPIs,
but possibly at the cost of completeness. For the features that are contained in it, it seems
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likely that the Oxford COVID-19 Government Response Tracker dataset will have the highest
quality, given the large team behind this dataset. However, as we have stated in various
sections of this paper: Given our experience with several public datasets and our own data
collection, we encourage fellow Covid-19 researchers to independently verify the quality of
public data they use, if feasible.
Appendix C. Mask prevalence survey
Volunteers and Amazon Mechanical Turk (AMT) workers were asked to fill out an online
survey between 25th March and 7th April 2020. The first-round volunteers were recruited
via Facebook posts and private emails, with a request to both complete the survey and
share it with their contacts, especially overseas contacts. Owing to a lack of geographical
coverage in the first round, a second round, surveying users of country-specific forums on
Reddit, was conducted and completed on 28th April.
The survey features three sets of questions, regarding:
1. the requirements or recommendations to wear masks in the participant’s home coun-
try. (This question was added in the second round.)
2. the percentage of mask-wearers they saw in public at weekly intervals between the
end of February and the beginning of April
3. the number of people in indoor public areas as a percentage of the usual number of
people seen in these areas at weekly intervals between the end of February and the
beginning of April
Both strategies (private word of mouth and public internet sampling) are likely to yield
non-representative samples owing to self-selection. This could yield poor results if mask
usage varies a lot within countries, for instance in large countries such as India and the
United States. However, we found a good deal of consistency in responses within coun-
tries on specified days. The average standard deviation of “percentage of population wear-
ing masks” within country-days was 18.6, while the same measure, between countries but
within days, was 28.6. Given this, we expect the inclusion of countries with even a sin-
gle response to give a better indication of mask-wearing behaviour in that country than
assuming such countries to have average levels.
Appendix C.1. Data transformation and combination with government orders
We computed a binary feature of mask-wearing, attributed to the middle day of each week
in the survey, by thresholding the average survey response for that week at 60%.
To create the mask-wearing feature used in our modelling, we combined the data from the
surveys with data on government orders requiring the the wearing of masks in public places
in the following way:
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• We only considered survey results for countries with at least 5 responses
• If there was either a government order or a mask-wearing start date according to the
survey results (but not both), we accepted that date
• If there was both a government order and a mask-wearing start date according to
survey results, we accepted whichever was earlier. An exception were cases where
the start date according to surveys was less than 3 days before the government order.
In these cases we accepted the date of the government order (because the temporal
resolution of the survey results was +/− 3.5 days)
Mask data in detail (sheet “combined”): LINK
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Appendix C.2. Data calibration
If we assume that, for country days with over 15 responses, the true number of people
wearing masks is given by the mean of the survey responses, we can estimate the misclas-
sification rate for different numbers of responses by randomly sampling responses for that
country day and comparing them with the sample mean excluding the selected responses.
Table C.8 represents the average from 100 iterations of this procedure.
Table C.8: Results of bootstrap simulation (n = 100) of misclassification rates
1 response per country 4 responses per country
False positives 4.2 1.8
True positives 22.6 23.4
False negatives 6.0 5.4
True negatives 87.25 89.5
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Appendix D. Sensitivity results
We replicate the posterior of the effectiveness of NPIs, showing its sensitivity to variations
of the assumptions and the data.
Recall that we show cumulative effects for two sets of NPIs: gatherings and business clo-
sures. This means that, e.g., a high sensitivity for closing some businesses will show up a
second time as a high sensitivity for closing most businesses. This overstates the number
of individual parameters αi which are sensitive. To illustrate this duplication, we have also
plotted the first sensitivity with cumulative effects (Figure D.10) and without (Figure D.11).
All other figures are cumulative.
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Figure D.10: Robustness to left-out / unobserved NPIs. Replications of the posterior in Figure EF for
the combined model while hiding each of the NPIs once. Note that we display cumulative effects for
gathering bans and business closures, so that any sensitivity of these NPIs is also cumulative, showing
up multiple times on the graph. The figures thus overstate the number of parameters αi which are
sensitive. Figure D.11 shows sensitivity without this accumulation.
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Figure D.11: Robustness to left-out / unobserved NPIs - with marginal / non-cumulative effects.
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Figure D.12: Sensitivity to including mobility data as additional ‘NPI’. Mobility data serves as a proxy
for unobserved behavior changes. Mobility data explains most of the effect of business closures and
stay-home-orders, which is expected as the effect of these NPIs is mediated through retail, recreation,
and workplace mobility. Results were nearly identical when excluding workplace mobility (not shown).
We did not experiment with other mobility categories such as groceries and pharmacy.
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Figure D.13: Sensitivity to mean delay from infection to confirmation (combined model). The default
mean is 10.1 days (including the incubation period); it is shifted over a window of 8 days in this figure.
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Figure D.14: Sensitivity to mean delay from infection to death (combined model). The default mean is
23.84 days (including the incubation period); it is shifted over a window of 8 days in this figure.
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Normal,  = 0.2
Normal,  = 10
Half Normal,  = 0.2
Figure D.15: Sensitivity to prior on the effectiveness parameters αi (combined model). The default prior
has αi normally distributed with mean 0 standard deviation σ= 0.2 (Appendix F). The alternative priors
we tested are 1) a very wide prior, with σ = 10 and a 2) Half-Normal prior that only allows for positive
effectiveness.
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Figure D.16: Sensitivity to the standard deviation of multiplicative noise ε(·)t ,c ∼ Lognormal(0,σN ) on new
infections (combined model). We vary σN . Deaths and cases have independent noise terms, with the
same standard deviation σN . Note that a larger noise scale implies that the rates of ascertainment
(testing) and fatality are allowed to change more rapidly. Predictably, results are less confident given
more noise. Our default value was chosen by cross-validation (with the validation log-likelihood).
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Confirmation: 15, Deaths: 15
Confirmation: 15, Deaths: 30
Confirmation: 30, Deaths: 15
Confirmation: 30, Deaths: 30
Figure D.17: Sensitivity to the dispersion of the output noise on deaths and confirmed cases (combined
model). We vary the parameter ψ, given in Appendix Appendix F. In our main model, we learned this
parameter.
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Figure D.18: Sensitivity to 6 randomly selected left out countries with >100 deaths. Note the Czech Re-
public is one of the countries implementing mask-wearing before April, explaining the higher sensitivity.
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Figure D.19: Sensitivity to excluding days with few cumulative cases. By default, we mask days in
each country before there were <100 cumulative cases, because imported cases could bias the numbers.
Changing to <500 cumulative cases removes a substantial fraction of our data.
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Figure D.20: Sensitivity to shifting the serial interval distribution. A shorter serial interval implies a
lower value of R0, so it is expected that the reductions in R will be smaller (since R0 will be small to
begin with). Indeed, smaller reductions are sufficient given a smaller R0.
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Figure D.21: Sensitivity to the mean of the hyperprior on R0,c
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Figure D.22: Sensitivity to counting schools as open/closed in Sweden. Sweden closed high schools and
universities on the 18th of March, but not elementary schools. We and Flaxman et al. counted this as
"schools closed", but Banholzer et al. counted this as "schools open". This was the largest difference
between our data on schools and Banholzer et al.
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Appendix E. Additional Results

















Figure E.23: MCMC stability results. Values are close to 1, indicating convergence.
Appendix E.1. Posterior Correlation
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Figures/FigureAR2.pdf
Figure E.24: Combined model posterior correlations. The parameters αi are typically negatively corre-
lated for NPIs which are often used together, such as stay-home-orders and suspending most businesses,
reflecting uncertainty about which NPI is reducing R. The effectiveness of the combination of two nega-
tively correlated NPIs may have narrower uncertainty estimates than the individual effects we plotted in
the main text and Appendix Appendix D.
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Figure E.29: Holdout predictions of deaths and cases for all 41 countries (combined model). Empty dots
are not shown to the model. 14 initial days are shown to the model, to enable inferring the basic R0. The
results show that our model makes sensible and well-calibrated forecasts over long time periods. There
are no predicted deaths in some regions because there were no recorded deaths yet in the first 14 days
with data.
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Growth reductions  of interventions αi i
Daily growth rate gt,cSerial interval
Product of active 
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 = 1 if  is onϕi,t,c i
For each intervention i
Figure F.41: Model overview. Purple nodes are observed or have a fixed distribution. The same structure
is used for both deaths and confirmed cases. Our primary model combines both observations; it splits
all nodes above the daily growth rate gt ,c into separate branches for deaths and cases.
Appendix F. Additional Modeling Details
Appendix F.1. Data Preprocessing
We perform the following data preprocessing:
• Our data for confirmed cases and deaths is given by the John Hopkins Centre for
Systems Science and Engineering24,25. We smooth this data by averaging the num-
ber of cases and deaths in a five day period around every day, assuming the data is
symmetric at the boundaries.
• We mask new cases before a country has reached 100 confirmed cases. This accounts
for cases being imported from other countries and rapid changes in testing regime
when the case count is small.
• To avoid bias from imported deaths, we mask new deaths before a country has reached
10 deaths.
• Days where there are zero cases or deaths do not provide information about the rela-
tive change in the size of the epidemic. Therefore, they are masked.
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Appendix F.2. Concise Model Description
Variables are indexed by intervention i , country c, and day t . All prior distributions are
independent.
• Data
1. NPI Activations: φi ,t ,c ∈ {0,1}.
2. Smoothed Observed Cases: Ct ,c .
3. Smoothed Observed Deaths: D t ,c .
• Prior Distributions
1. Country-specific R0,
R0,c =exp(R̄ +σR zc ) (F.1)
R̄ ∼ Student T(µ= log(3.25),σ= 0.2,ν= 10) (F.2)
σR ∼ Half Student T(σ= 0.2,ν= 10) (F.3)
zc ∼ Normal(µ= 0,σ2 = 1) (F.4)
2. NPI Effectiveness:
αi ∼ Normal(µ= 0,σ2R = 0.2) (F.5)
(F.6)
3. Infection Initial Counts.
N (C )0,c = exp(ζ(C )c ) (F.7)
N (D)0,c = exp(ζ(D)c ) (F.8)
ζ(C )c ∼ Normal(µ= 0,σ2 = 502) (F.9)
ζ(D)c ∼ Normal(µ= 0,σ2 = 502) (F.10)
(F.11)
4. Observation Noise Dispersion Parameter
Ψ∼ Half Normal(µ= 0,σ2 = 52) (F.12)
• Hyperparameters
1. Infection Noise Scale, σN = 0.1 (selected by cross-validation).
2. Serial Interval Parameters. The serial interval is assumed to have a Gamma
distribution with α= 1.87 and β= 0.28.30
3. Delay Distributions. The time from infection to confirmation is assumed to be
the sum of the incubation period and the time taken from symptom onset to lab-
oratory confirmation. Therefore, the time taken from infection to confirmation,
T (C ) is:
T (C ) ∼ Gamma(µ= 5.1, σ
µ
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The time from infection to death is assumed to be the sum of the incubation
period and the time taken from symptom onset to death. Therefore, the time
taken from infection to death, T (D) is:31–34
T (D) ∼ Gamma(µ= 5.1, σ
µ
= 0.86)+Negative Binomial(µ= 5.25,α= 1.57), (F.14)
where α is known as the dispersion parameter. Caution: larger values of α
correspond to a smaller variance, and less dispersion. With our parameterisation,
the variance of the Negative Binomial distribution is µ+ µ2α .
For computational efficiency, we discretise this distribution using Monte Carlo
sampling. We therefore form discrete arrays, πC[i ] and πD[i ] where the value of
πC[i ] corresponds to the probability of the delay being i days. We truncate πC
to a maximum delay of 31 days and πD to a maximum delay of 63 days.
• Infection Model
1. Rt ,c = R0,c ·exp
(−∑9i=1αi φi ,t ,c).







−1 where α and β are the parameters of the serial interval
distribution. This is the exact conversion under exponential growth, following eq.
(2.9) in Wallinga & Lipsitch.29 (Note that we use daily growth rates.)
3.




(gτ,c +1) ·expε(C )τ,c
]
, (F.15)




(gτ,c +1) ·expε(D)τ,c )
]
,with noise (F.16)
ε(C )τ,c ∼ Normal(µ= 0,σ2 =σ2N ), (F.17)
ε(D)τ,c ∼ Normal(µ= 0,σ2 =σ2N ) (F.18)
N (C )t ,c represents the number of daily new infections at time t in country c who
will eventually be tested positive (N (C )t ,c similar but for infections who will pass
away).
• Observation Model: We use discrete convolutions to produce the expected number




N (C )t−τ,cπC [τ], (F.19)
D̄ t ,c =
64∑
τ=1
N (D)t−τ,cπD [τ]. (F.20)
Finally, the output distribution follows a Negative Binomial noise distribution as pro-
posed by Flaxman et al.2
Ct ,c ∼ Negative Binomial(µ= C̄t ,c ,α=Ψ) (F.21)
D t ,c ∼ Negative Binomial(µ= D̄ t ,c ,α=Ψ) (F.22)
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α is the dispersion parameter of the distribution. Caution: larger values of α cor-
respond to a smaller variance, and less dispersion. With our parameterisation, the
variance of the Negative Binomial distribution is µ+ µ2α , so that smaller observations
are relatively more noisy.
This model was implemented in PyMC356 with the NUTS MCMC sampling algorithm37.
Appendix F.3. Interpreting αi - Proof Sketch
We have previously noted that the effectiveness of each NPI, αi , may depend on the pres-
ence of other NPIs. For example, masks may be less effective when a stay-at-home order
has been issued because more of the remaining transmission occurs in private spaces. We
claimed that, in such a situation, we can roughly interpret the inferred effect αi of NPI i
as the average additional effect it had in the contexts (i.e., the sets of simultaneously active
NPIs) in which it was active. The average is over days and countries in which it was active.
Here, we formalize this claim for the maximum likelihood estimator (MLE) of αi with a
simplified model in which we know the true values of Rc,t (perhaps from another model).
In reality, these values are not known but rather estimated by our model. Although, we
are performing Bayesian inference, the posterior density will be high where the likelihood
is high, and thus this interpretation is still insightful. The maximum of our posterior (the
MAP) will be close to the maximum of the likelihood (the MLE) since the influence of our
prior distribution on αi is, empirically, small.
Simplified Model. We have NPI activations φi ,c,t , where φi ,c,t = 1 represents NPI i being
active in country c on day t . Assume that the true values of Rc,t ,R0,c have been provided to
us. Our simplified model is:
Rpredictedc,t = R0,c exp[−
∑
i
αiφi ,c,t ], (F.23)
logRc,t = logRpredictedc,t + zc,t where zc,t ∼N (0,σ2N ). (F.24)
The log-likelihood can be written as:
L ({αi }) = log p({Rt ,c }|{Ro,c }, {αi }, {φi ,c,t }) (F.25)
=∑
c,t





(logRpredictedc,t − logRc,t )2 +constant. (F.26)
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(logRpredictedc,t − logRc,t )φi ,c,t
∝ ∑
c,t∈i active
(logRpredictedc,t − logRc,t ). (F.27)
Finally, setting ∂L∂αi = 0 gives. ∑
c,t∈i active






α jφ j ,c,t − logRc,t ) = NiαMLEi , (F.28)









α jφ j ,c,t ]︸ ︷︷ ︸
Predicted logR based on other NPIs
− logRc,t ). (F.29)
αMLEi is the average additional effect that NPI i had over the simultaneously active NPIs,
where the average is taken over the days where NPI i was active.
Appendix F.4. Choice of σN
The value of σN is chosen by evaluating holdout country performance across a range of
different values of σN .
Figure F.42 shows heldout predictive performance for The Netherlands across different val-
ues of σN . We choose values σN = 0.2 because it is the gives good holdout calibration. We
included other countries in our analysis, leading to similar results.
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Figure F.42: Holdout performance for The Netherlands for a range of different noise scales, σN . Note
that this graph was produced with a hyperprior on the effectiveness of each intervention, removed in
the final version of the model.
64
 . CC-BY-NC 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted June 2, 2020. .https://doi.org/10.1101/2020.05.28.20116129doi: medRxiv preprint 
Appendix G. Preference survey details
Appendix G.1. Description of NPIs as shown to participants
All school closed
All levels of schools are closed.
Restrictions on gatherings
All events and gatherings above a certain size are banned.
Most risky businesses closed
Selected businesses with a high risk of infection are closed, such as most restaurants or bars.
All non-essential businesses closed
Essential businesses like grocery stores and pharmacies remain open, but all other customer-
facing businesses are closed.
Stay-at-home order
People are required to not leave their house, with exceptions for daily exercise, grocery
shopping, and essential trips. Usually, this means that many non-essential businesses are
closed as well. You can usually still go to work, but many companies will switch to work-
from-home where possible.
Public health authorities tracing contacts
People who are infected have to share their contact history with epidemiologists and at-risk
people are quarantined.
Special precautions in clinics and hospitals
People are screened for COVID before entering hospitals. People with COVID symptoms are
given a face mask before they enter a clinic, or have to go to a dedicated COVID clinic.
Wearing masks
Wearing a face mask is mandatory when in the public.
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Appendix G.2. Example question
This survey focuses on how socially and personally burdensome people perceive various
COVID-19 mitigation measures to be.
In order to understand how to best react to the COVID-19 pandemic, we need to find
out how different mitigation measures compare to each other. In this survey, we are only
interested in how mitigation measures affect people’s personal lives, but not in how effective
different measures are at reducing the spread of COVID-19 nor what their effects are on the
economy as a whole.
As such, we only ask about how different measures affect your life, not about how they
affect the course of the pandemic.
Which of these mitigation measures would you find least burdensome, and which most
burdensome?
The following shows a selection of mitigation measures that may oc-
cur as part of the response against Covid-19. Note that the measures
differ in type and duration of deployment. Consider how burden-
some would the measures be if they had the same effect on the





















hospitals for 1 week
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Appendix G.3. Estimation of perceived intervention costs (ratio scale) from
utility scores (interval scale)
Let u(i ,d) be the average population utility score for a pair of intervention i and duration
d . We now make two additional assumptions, which are well justified by the empirical data
(Figure 7):
1. The utility can be expressed as the sum of two terms, where one term only depends
on the intervention and the other term only on the duration: u(i ,d) = ai +b(d)
2. The dependence on duration is logarithmic: b(d) = b lnd
We can thus express the utility score as: u(i ,d) = ai +b lnd
We can then define the cost of intervention i as ci = e
ai
b . This cost has the desired ratio
property: The cost of intervention i2 is x times larger than the cost of intervention i1 iff the
average survey participant would be indifferent between enduring i2 for some duration d ′
and enduring i1 for duration x ·d ′.











⇔ a2 = a1 +b ln x
⇔ b lnd ′+a2 = a1 +b ln x +b lnd ′
⇔ u(i2,d ′) = u(i1, xd ′)
We use a linear model to find parameters ai and b, using utility scores for all pairs of
measures and durations.
67
 . CC-BY-NC 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)








60 or older 24 7%





No answer 61 18%
Martial status






No answer 62 19%
Highest level of education
Less than high school degree 1 0%
High school degree or equivalent (e.g. GED) 32 10%
Some college but no degree 57 17%
Associate degree 30 9%
Bachelor degree 127 38%
Graduate degree 28 8%
No answer 59 18%
Employment status
Employed, working 1-39 hours per week 79 24%
Employed, working 40 or more hours per week 156 47%
Not employed, looking for work 9 3%
Not employed, NOT looking for work 7 2%









Continued on next page
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$100,000 or more 40 12%
No answer 65 20%
Appendix H. Assumptions and limitations
Appendix H.1. Limitations of the data
We only record NPIs implemented nationally. For example, several regions in Germany
implemented stay-at-home orders even though this was not ordered nationally. Regional
orders do not appear in our data. Additionally, while we included more NPIs than previous
work (Table 1), there are many NPIs for which we were not able to collect enough high-
quality data for our modeling, such as public cleaning or changes to public transportation.
Appendix H.2. Model Limitations
Independence of country and time. We assume that the effect of NPIs on growth rates is
similar across countries and time. However, the exact implementation and adherence of
each NPIs is likely to vary. Our uncertainty estimates in Figure 6 account for these problems
only to a strictly limited degree. Additionally, different countries have different cultural
norms and age profiles, affecting the degree to which a particular intervention is effective.
For example, a country where a higher proportion of the population is in education will
likely observe a larger effect from a government order to close schools and universities.
Unobserved changes in behavior. Our method assumes that changes in the reproduction
number are caused by the observed NPIs rather than unobserved factors such as sponta-
neous behaviour changes. We test the sensitivity of our results to unobserved interventions
by hiding observed NPIs and by including mobility data. Our conclusions were stable (see
Figure D.15), but removing our most effective NPI, school closure, increased the inferred
effectiveness for gathering bans and business closures.
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Testing, reporting, and the IFR. Our model can account for differences in testing (and
IFR/reporting) between countries and over time, as discussed in Section 2). However,
we have not used additional data on testing to validate if it does so reliably. Our model may
struggle to account for changes in the testing regime—for instance, when a country reaches
its testing capacity so that the ascertainment rate declines exponentially. An exponential
decline would have the same effect on observations as an unobserved NPI. Consequently,
we cannot quantify its effect on our results (though the sensitivity analyses look promising).
Interaction between NPIs. As discussed in Section 3, our model only reports the average
additional effect each NPI had in the contexts where it was active in our data (derivation in
Appendix F). Figure 6 shows these contexts, aiding interpretation. The effectiveness of an
NPI can only be extrapolated to other contexts if its effect does not depend on the context.
Growth rates. The functional form of the relationship between the daily growth rate in the
number of infections g and the reproductive number R holds exactly when the epidemic
is in its exponential growth phase, but becomes less accurate as the number of susceptible
people in a population decreases and/or control measures are implemented.
Signalling effect of NPIs. As we explained in Section 4 for school closures, we do not dis-
tinguish between the direct effect of an NPI and its indirect effect as it signals the gravity
of the situation to the public. Conversely, lifting interventions may also have a signalling
effect.
Subgroups. We work under the standard assumption of a well-mixed population (Anderson
& May57). This could affect results in various ways. For example, suppose country A tests
an older demographic than country B, and we are considering the effect of an NPI that
mostly affects the older demographic (for example, isolating the elderly). Then the NPI will
appear to have a greater effect on confirmed cases in country A, breaking the assumption
that effects are stable across countries.
Appendix H.3. Limitations of burden estimation
We estimate the burden that different NPIs put on people’s lives. Of course, implementation
of NPIs has many other costs (and benefits) than just the encumbrance on daily life. Many
long-term costs of NPIs will also be codetermined by the economic policy response they
engender, their impacts on global supply chains, their structural damage to networks of
business contacts, and many other similar effects. Estimating these long-term impacts might
be prohibitively difficult and is out of scope for this study. Nevertheless, these factors should
be considered for policy decisions to the degree possible.
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Our preference data is a sample of US residents only, in particular those working on the
Amazon Mechanical Turk platform. This may limit the international applicability of our
cost-effectiveness estimates. Even though recruitment on Amazon Mechanical Turk usually
results in greater demographic diversity than typical internet samples,38 there will still be
selection bias. It’s also important to note that, due to ethical reasons, the sample does not
include participants under 18 years of age, which is a main limitation when estimating the
perceived costs of closing schools.
Finally, using the mean population preference for policy decisions may be problematic in
itself. For example, the closure of schools will likely strongly affect the parents of school
children but pose little burden on the majority of people that are not parents of school
children. The mean burden of closing schools may then just be moderate, but for policy
decisions it is necessary to also take considerations around fairness and inequality into
account.
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